Market Assessment

Market Opportunity Assessment of Trio® Blood Glucose Meter Technology

Pepex Biomedical (Saint Louis, Missouri) has designed an integrated blood glucose meter that incorporates a lancet and sensor technology into a single meter. The glucose meter uses a monofilament sensor capable of detecting blood glucose levels with a very low volume blood sample. Pepex Biomedical engaged Frost & Sullivan to evaluate this new technology and determine its market opportunity.

Frost & Sullivan is a global strategic marketing company that specializes in health care technologies. Frost & Sullivan interviewed 200 diagnosed diabetics, 6 diabetes educators, 5 endocrinologists, and 14 manufacturers of biosensors, blood glucose meters, or other clinical diagnostic or patient monitoring equipment.

Download the Report arrow
Frost & Sullivan believes
there is a market opportunity
for Pepex Biomedical’s
integrated blood glucose meter
About Pepex
Management Team
In the News
Market Reports
Our Mission
Our Technology
Trio® Total
Ex-Vivo Catheter
Indwelling Micro Sensors
Multi-Parameter Sensors
Contact Pepex

Ph. (314) 633-5053
Email »

© Pepex Biomedical. Web Design by Darren Pace